70.92
전일 마감가:
$73.05
열려 있는:
$71.35
하루 거래량:
911.82K
Relative Volume:
1.86
시가총액:
$5.27B
수익:
-
순이익/손실:
$-224.29M
주가수익비율:
-18.18
EPS:
-3.9
순현금흐름:
$-185.06M
1주 성능:
-8.06%
1개월 성능:
-5.41%
6개월 성능:
-30.67%
1년 성능:
-5.55%
Nuvalent Inc Stock (NUVL) Company Profile
명칭
Nuvalent Inc
전화
508-446-2272
주소
ONE BROADWAY, 14TH FLOOR, CAMBRIDGE
NUVL을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
NUVL
Nuvalent Inc
|
70.92 | 5.27B | 0 | -224.29M | -185.06M | -3.90 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
484.82 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
634.23 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
591.87 | 36.10B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
270.02 | 35.03B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
272.17 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Nuvalent Inc Stock (NUVL) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-03-14 | 업그레이드 | UBS | Neutral → Buy |
2024-12-30 | 개시 | H.C. Wainwright | Buy |
2024-10-24 | 개시 | UBS | Neutral |
2024-08-29 | 개시 | Barclays | Overweight |
2024-04-17 | 개시 | Jefferies | Buy |
2024-04-01 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
2024-02-28 | 재개 | Guggenheim | Buy |
2024-02-23 | 개시 | Robert W. Baird | Outperform |
2023-09-27 | 개시 | Stifel | Buy |
2023-08-08 | 개시 | SVB Securities | Market Perform |
2023-07-24 | 개시 | Guggenheim | Buy |
2023-01-18 | 개시 | Wedbush | Outperform |
2022-06-24 | 개시 | BMO Capital Markets | Outperform |
모두보기
Nuvalent Inc 주식(NUVL)의 최신 뉴스
Teacher Retirement System of Texas Boosts Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World
Why Nuvalent (NUVL) Is Among the Best Mid Cap Biotech Stocks to Buy - Insider Monkey
Nuvalent chief development officer sells shares worth $292,468 By Investing.com - Investing.com Philippines
Nuvalent chief development officer sells shares worth $292,468 - Investing.com India
10 Best Mid Cap Biotech Stocks to Buy - Insider Monkey
Breakthrough Cancer Drug Data: New Brain-Penetrant Therapy Shows Promise Against Resistant Tumors - Stock Titan
How the (NUVL) price action is used to our Advantage - news.stocktradersdaily.com
Raymond James Financial Inc. Acquires Shares of 133,964 Nuvalent, Inc. (NASDAQ:NUVL) - Defense World
Nuvalent CEO Porter sells $2.05 million in stock By Investing.com - Investing.com Australia
Nuvalent CEO Porter sells $2.05 million in stock - Investing.com
Victory Capital Management Inc. Cuts Stock Position in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World
Charles Schwab Investment Management Inc. Buys 7,742 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - Defense World
US Bancorp DE Invests $90,000 in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World
Bank of New York Mellon Corp Increases Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World
UBS Upgrades Nuvalent (NUVL) - Nasdaq
Nuvalent upgraded to Buy from Neutral at UBS - TipRanks
UBS Upgrades Nuvalent to Buy From Neutral, Maintains $100 Price Target -March 14, 2025 at 07:24 am EDT - Marketscreener.com
Principal Financial Group Inc. Cuts Position in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World
Nuvalent, Inc. (NASDAQ:NUVL) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
HC Wainwright Has Negative Forecast for Nuvalent Q1 Earnings - Defense World
Nuvalent’s (NUVL) Buy Rating Reaffirmed at HC Wainwright - Defense World
H.C. Wainwright maintains Buy on Nuvalent stock, $110 target By Investing.com - Investing.com Canada
New York State Common Retirement Fund Sells 2,495 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - Defense World
Where are the Opportunities in (NUVL) - news.stocktradersdaily.com
Rhumbline Advisers Has $3.95 Million Stake in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World
Nuvalent’s Strategic Advances in NSCLC Trials Justify Buy Rating - TipRanks
Nuvalent to Participate in Upcoming March Investor Conferences - Citizentribune
Nuvalent, Inc. Reports 2024 Financial Results and Pipeline Progress - TipRanks
Nuvalent Outlines Pipeline and Business Progress, Reiterates Key Anticipated Milestones, and Reports Fourth Quarter and Full Year 2024 Financial Results - The Malaysian Reserve
Nuvalent's Q4 Net Loss Widens -February 27, 2025 at 07:14 am EST - Marketscreener.com
Earnings Flash (NUVL) Nuvalent Posts Q4 Net Loss $1.05 a Share, vs. FactSet Est of $1.08 Loss - Marketscreener.com
Nuvalent, Inc. SEC 10-K Report - TradingView
Nuvalent director Shair sells $156,863 in class A common stock By Investing.com - Investing.com Australia
State of New Jersey Common Pension Fund D Has $1.81 Million Stock Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World
Nuvalent director Shair sells $156,863 in class A common stock - Investing.com India
Can This Biotech Executive's $6.3B Deal Experience Transform Climb Bio's Future? - Stock Titan
Nuvalent (NUVL) Projected to Post Earnings on Tuesday - Defense World
Nuvalent CEO sells stock worth over $2.1 million By Investing.com - Investing.com South Africa
Nuvalent CEO sells stock worth over $2.1 million - Investing.com India
(NUVL) Proactive Strategies - Stock Traders Daily
Nuvalent (NUVL) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Nuvalent, Inc. (NASDAQ:NUVL) Receives $112.36 Consensus Target Price from Analysts - MarketBeat
Q1 Earnings Estimate for Nuvalent Issued By Leerink Partnrs - MarketBeat
abrdn plc Buys 9,241 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Nuvalent, Inc. (NASDAQ:NUVL) Receives $112.36 Consensus PT from Brokerages - Defense World
10 Mid-Cap Stocks Insiders Are Selling Recently - Insider Monkey
Why Insiders Are Selling Nuvalent, Inc. (NUVL) Recently - Insider Monkey
KBC Group NV Boosts Stock Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World
Nuvalent Inc (NUVL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):